Literature DB >> 29437036

Five-year outcome of a randomised trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: the NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial (NEXT).

Masahiro Natsuaki1, Ken Kozuma, Takeshi Morimoto, Kazushige Kadota, Toshiya Muramatsu, Yoshihisa Nakagawa, Takashi Akasaka, Keiichi Igarashi Hanaoka, Kengo Tanabe, Yoshihiro Morino, Hideo Nishikawa, Takeshi Kimura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29437036     DOI: 10.4244/EIJ-D-17-01050

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  6 in total

Review 1.  Drug-eluting stent thrombosis: current and future perspectives.

Authors:  Shoichi Kuramitsu; Shinjo Sonoda; Kenji Ando; Hiromasa Otake; Masahiro Natsuaki; Reo Anai; Yasuhiro Honda; Kazushige Kadota; Yoshio Kobayashi; Takeshi Kimura
Journal:  Cardiovasc Interv Ther       Date:  2021-01-13

2.  Biodegradable polymer versus second-generation durable polymer drug-eluting stents in patients with coronary artery disease: A meta-analysis.

Authors:  James J Wu; Joshua A H Way; Probal Roy; Andy Yong; Harry Lowe; Leonard Kritharides; David Brieger
Journal:  Health Sci Rep       Date:  2018-10-05

3.  Twelve-month comparative analysis of clinical outcomes using biodegradable polymer-coated everolimus-eluting stents versus durable polymer-coated everolimus-eluting stents in all-comer patients.

Authors:  Atul Abhyankar; Manjinder Singh Sandhu; Raghava Sarma Polavarapu
Journal:  Indian Heart J       Date:  2019-05-03

4.  Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial.

Authors:  Andrés Iñiguez; Bernard Chevalier; Gert Richardt; Antoinette Neylon; Victor A Jiménez; Ran Kornowski; Didier Carrie; Raul Moreno; Emanuele Barbato; Antoni Serra-Peñaranda; Vincenzo Guiducci; Mariano Valdés-Chávarri; Junji Yajima; William Wijns; Shigeru Saito
Journal:  Catheter Cardiovasc Interv       Date:  2019-04-29       Impact factor: 2.692

Review 5.  COBRA PzF™ coronary stent in clinical and preclinical studies: setting the stage for new antithrombotic strategies?

Authors:  Anne Cornelissen; Atsushi Sakamoto; Yu Sato; Rika Kawakami; Masayuki Mori; Kenji Kawai; Matthew Kutyna; Raquel Fernandez; Saikat Ghosh; Mark Barakat; Renu Virmani; Aloke Finn
Journal:  Future Cardiol       Date:  2021-09-15

6.  Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study.

Authors:  Xiao-Fang Tang; Yuan-Liang Ma; Ying Song; Jing-Jing Xu; Yi Yao; Chen He; Huan-Huan Wang; Ping Jiang; Lin Jiang; Ru Liu; Zhan Gao; Xue-Yan Zhao; Shu-Bin Qiao; Yue-Jin Yang; Run-Lin Gao; Bo Xu; Jin-Qing Yuan
Journal:  Cardiovasc Diabetol       Date:  2018-08-14       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.